Log In
Print this Print this

Humacyl, HumaGraft, Human Acellular Vascular Graft (HAVG) (Tissue-engineered vascular grafts (TEVGs))

  Manage Alerts
Collapse Summary General Information
Company Humacyte Inc.
DescriptionDecellularized bioengineered blood vessels
Molecular Target Not applicable
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today